Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-15 Sale | 2024-04-17 5:05 pm | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 15,000 | $18.19 | $272,871 | 504,389 (Direct) | View |
| 2024-03-14 Sale | 2024-03-18 5:03 pm | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 15,000 | $21.86 | $327,942 | 519,389 (Direct) | View |
| 2024-03-05 Sale | 2024-03-07 6:05 pm | REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer | 12,878 | $28.36 | $365,220 | 138,469 (Direct) | View |
| 2024-02-14 Sale | 2024-02-16 6:28 pm | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 15,000 | $16.76 | $251,349 | 534,389 (Direct) | View |
| 2024-01-16 Sale | 2024-01-18 6:39 pm | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 45,000 | $15.18 | $682,992 | 549,389 (Direct) | View |
| 2024-01-03 Sale | 2024-01-04 4:23 pm | REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer | 17,237 | $17.39 | $299,789 | 158,067 (Direct) | View |
| 2023-12-19 Sale | 2023-12-21 1:38 pm | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 45,000 | $19.68 | $885,825 | 577,959 (Direct) | View |
| 2023-01-03 Sale | 2023-01-05 4:06 pm | REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer | 3,138 | $22.17 | $69,559 | 146,918 (Direct) | View |
| 2022-08-30 Sale | 2022-08-31 6:01 pm | REGENXBIO Inc. | RGNX | Vasista Vittal Chief Financial Officer | 2,400 | $30.24 | $72,573 | 135,160 (Direct) | View |
| 2022-08-04 Sale | 2022-08-08 4:04 pm | REGENXBIO Inc. | RGNX | Vasista Vittal Chief Financial Officer | 17,680 | $35.18 | $622,035 | 137,560 (Direct) | View |
| 2022-08-01 Sale | 2022-08-03 5:26 pm | REGENXBIO Inc. | RGNX | Vasista Vittal Chief Financial Officer | 2,400 | $31.25 | $75,012 | 155,240 (Direct) | View |
| 2022-07-13 Sale | 2022-07-15 4:18 pm | REGENXBIO Inc. | RGNX | Vasista Vittal Chief Financial Officer | 4,800 | $30.01 | $144,028 | 157,640 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-15 Exercise | 2024-04-17 5:05 pm | N/A N/A | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 15,000 | $3.76 | 504,389 (Direct) | View |
| 2024-04-15 Exercise | 2024-04-17 5:05 pm | N/A 2025-05-19 | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 15,000 | $0 | 504,389 (Direct) | View |
| 2024-03-19 Exercise | 2024-03-21 5:20 pm | N/A N/A | REGENXBIO Inc. | RGNX | Vasista Vittal Chief Financial Officer | 20,041 | $3.76 | 246,534 (Direct) | View |
| 2024-03-19 Exercise | 2024-03-21 5:20 pm | N/A 2025-05-19 | REGENXBIO Inc. | RGNX | Vasista Vittal Chief Financial Officer | 20,041 | $0 | 246,534 (Direct) | View |
| 2024-03-14 Exercise | 2024-03-18 5:03 pm | N/A N/A | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 15,000 | $3.76 | 519,389 (Direct) | View |
| 2024-03-14 Exercise | 2024-03-18 5:03 pm | N/A 2025-05-19 | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 15,000 | $0 | 519,389 (Direct) | View |
| 2024-03-05 Exercise | 2024-03-07 6:05 pm | N/A 2033-01-03 | REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer | 12,878 | $0 | 138,469 (Direct) | View |
| 2024-03-05 Exercise | 2024-03-07 6:05 pm | N/A N/A | REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer | 12,878 | $22.25 | 138,469 (Direct) | View |
| 2024-02-14 Exercise | 2024-02-16 6:28 pm | N/A N/A | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 15,000 | $3.76 | 534,389 (Direct) | View |
| 2024-02-14 Exercise | 2024-02-16 6:28 pm | N/A 2025-05-19 | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 15,000 | $0 | 534,389 (Direct) | View |
| 2024-01-16 Exercise | 2024-01-18 6:39 pm | N/A N/A | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 45,000 | $3.76 | 549,389 (Direct) | View |
| 2024-01-16 Exercise | 2024-01-18 6:39 pm | N/A 2025-05-19 | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 45,000 | $0 | 549,389 (Direct) | View |
| 2024-01-02 Tax Withholding | 2024-01-04 4:34 pm | N/A N/A | REGENXBIO Inc. | RGNX | Simpson Curran Chief Oper. & Tech. Officer | 8,120 | $17.95 | 184,377 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:34 pm | N/A 2034-01-02 | REGENXBIO Inc. | RGNX | Simpson Curran Chief Oper. & Tech. Officer | 99,512 | $0 | 184,377 (Direct) | View |
| 2024-01-02 Tax Withholding | 2024-01-04 4:23 pm | N/A N/A | REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer | 10,385 | $17.95 | 158,067 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:23 pm | N/A 2034-01-02 | REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer | 82,926 | $0 | 158,067 (Direct) | View |
| 2022-06-30 Option Award | 2024-01-04 4:22 pm | N/A N/A | REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer | 728 | $21 | 185,903 (Direct) | View |
| 2023-06-30 Option Award | 2024-01-04 4:22 pm | N/A N/A | REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer | 1,123 | $16.99 | 185,903 (Direct) | View |
| 2024-01-02 Tax Withholding | 2024-01-04 4:22 pm | N/A N/A | REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer | 8,410 | $17.95 | 185,903 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:22 pm | N/A 2034-01-02 | REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer | 99,512 | $0 | 185,903 (Direct) | View |
| 2024-01-02 Tax Withholding | 2024-01-04 4:17 pm | N/A N/A | REGENXBIO Inc. | RGNX | Vasista Vittal Chief Financial Officer | 4,534 | $17.95 | 302,806 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:17 pm | N/A 2034-01-02 | REGENXBIO Inc. | RGNX | Vasista Vittal Chief Financial Officer | 92,339 | $0 | 302,806 (Direct) | View |
| 2024-01-02 Tax Withholding | 2024-01-04 4:07 pm | N/A N/A | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 11,357 | $17.95 | 713,285 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:07 pm | N/A 2034-01-02 | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 369,353 | $0 | 713,285 (Direct) | View |
| 2024-01-02 Tax Withholding | 2024-01-04 4:06 pm | N/A N/A | REGENXBIO Inc. | RGNX | Christmas Patrick J. Chief Legal Officer | 7,893 | $17.95 | 170,704 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:06 pm | N/A 2034-01-02 | REGENXBIO Inc. | RGNX | Christmas Patrick J. Chief Legal Officer | 89,560 | $0 | 170,704 (Direct) | View |
| 2023-12-19 Exercise | 2023-12-21 1:38 pm | N/A N/A | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 43,500 | $3.76 | 577,959 (Direct) | View |
| 2023-12-19 Exercise | 2023-12-21 1:38 pm | N/A 2025-05-19 | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 45,000 | $0 | 577,959 (Direct) | View |
| 2023-12-19 Exercise | 2023-12-21 1:38 pm | N/A N/A | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 1,500 | $0.85 | 577,959 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-06 5:14 pm | N/A 2033-06-02 | REGENXBIO Inc. | RGNX | Fox Allan M. Director | 21,378 | $0 | 2,906,854 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-06 5:13 pm | N/A 2033-06-02 | REGENXBIO Inc. | RGNX | Tasse Daniel Director | 21,378 | $0 | 24,388 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-06 5:12 pm | N/A 2033-06-02 | REGENXBIO Inc. | RGNX | STUMP DAVID C Director | 21,378 | $0 | 24,388 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-06 5:12 pm | N/A 2033-06-02 | REGENXBIO Inc. | RGNX | MIGAUSKY GEORGE V Director | 21,378 | $0 | 24,388 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-06 5:12 pm | N/A 2033-06-02 | REGENXBIO Inc. | RGNX | Glucksmann Alexandra Director | 21,378 | $0 | 24,388 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-06 5:12 pm | N/A 2033-06-02 | REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director | 21,378 | $0 | 24,388 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-06 5:11 pm | N/A 2033-06-02 | REGENXBIO Inc. | RGNX | Bennett Jean Director | 21,378 | $0 | 24,388 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-06 5:11 pm | N/A 2033-06-02 | REGENXBIO Inc. | RGNX | Zachary Jennifer Director | 21,378 | $0 | 27,398 (Direct) | View |
| 2023-05-31 Exercise | 2023-06-02 4:12 pm | N/A 2024-09-24 | REGENXBIO Inc. | RGNX | Vasista Vittal Chief Financial Officer | 35,000 | $0 | 215,001 (Direct) | View |
| 2023-05-31 Exercise | 2023-06-02 4:12 pm | N/A N/A | REGENXBIO Inc. | RGNX | Vasista Vittal Chief Financial Officer | 35,000 | $0.85 | 215,001 (Direct) | View |
| 2023-01-03 Tax Withholding | 2023-01-05 4:06 pm | N/A N/A | REGENXBIO Inc. | RGNX | Vasista Vittal Chief Financial Officer | 1,333 | $22.68 | 246,234 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 4:06 pm | N/A 2033-01-03 | REGENXBIO Inc. | RGNX | Vasista Vittal Chief Financial Officer | 112,407 | $0 | 246,234 (Direct) | View |
| 2023-01-03 Tax Withholding | 2023-01-05 4:06 pm | N/A N/A | REGENXBIO Inc. | RGNX | Simpson Curran Chief Oper. & Tech. Officer | 2,076 | $22.68 | 145,971 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 4:06 pm | N/A 2033-01-03 | REGENXBIO Inc. | RGNX | Simpson Curran Chief Oper. & Tech. Officer | 120,931 | $0 | 145,971 (Direct) | View |
| 2023-01-03 Tax Withholding | 2023-01-05 4:06 pm | N/A N/A | REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer | 1,837 | $22.68 | 146,918 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 4:06 pm | N/A 2033-01-03 | REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer | 134,743 | $0 | 146,918 (Direct) | View |
| 2023-01-03 Tax Withholding | 2023-01-05 4:06 pm | N/A N/A | REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer | 2,058 | $22.68 | 145,936 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 4:06 pm | N/A 2033-01-03 | REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer | 118,916 | $0 | 145,936 (Direct) | View |
| 2023-01-03 Tax Withholding | 2023-01-05 4:06 pm | N/A N/A | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 9,308 | $22.68 | 620,221 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 4:06 pm | N/A 2033-01-03 | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 319,685 | $0 | 620,221 (Direct) | View |
| 2023-01-03 Tax Withholding | 2023-01-05 4:06 pm | N/A N/A | REGENXBIO Inc. | RGNX | Christmas Patrick J. Chief Legal Officer | 1,843 | $22.68 | 145,556 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 4:06 pm | N/A 2033-01-03 | REGENXBIO Inc. | RGNX | Christmas Patrick J. Chief Legal Officer | 124,459 | $0 | 145,556 (Direct) | View |
| 2022-06-03 Option Award | 2022-06-07 4:26 pm | N/A 2032-06-03 | REGENXBIO Inc. | RGNX | Zachary Jennifer Director | 35,759 | $0 | 35,759 (Direct) | View |
| 2022-06-03 Option Award | 2022-06-07 4:23 pm | N/A 2032-06-03 | REGENXBIO Inc. | RGNX | Tasse Daniel Director | 18,334 | $0 | 18,334 (Direct) | View |
| 2022-06-03 Option Award | 2022-06-07 4:22 pm | N/A 2032-06-03 | REGENXBIO Inc. | RGNX | STUMP DAVID C Director | 18,334 | $0 | 18,334 (Direct) | View |
| 2022-06-03 Option Award | 2022-06-07 4:21 pm | N/A 2032-06-03 | REGENXBIO Inc. | RGNX | MIGAUSKY GEORGE V Director | 18,334 | $0 | 18,334 (Direct) | View |
| 2022-06-03 Option Award | 2022-06-07 4:20 pm | N/A 2032-06-03 | REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director | 18,334 | $0 | 18,334 (Direct) | View |
| 2022-06-03 Option Award | 2022-06-07 4:18 pm | N/A 2032-06-03 | REGENXBIO Inc. | RGNX | Glucksmann Alexandra Director | 18,334 | $0 | 18,334 (Direct) | View |
| 2022-06-03 Option Award | 2022-06-07 4:17 pm | N/A 2032-06-03 | REGENXBIO Inc. | RGNX | Fox Allan M. Director | 18,334 | $0 | 18,334 (Direct) | View |